Home > Back to Publisher > Report Information

Pharmaceutical Markets in India

Kalorama Information
April 1, 2009
96 Pages - SKU: KLI2155338

Abstract Table of Contents Search inside this report Related Reports

Countries covered: India

The pharmaceutical market in India ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be essential for pharmaceutical companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market. This report Pharmaceutical Market in India provides market watchers with needed information on this growing market, including:

Market Size and Forecast
Indian Market Share of Key Competitors
Population and Epidemilogical Statistics for the Indian Market
Pharmaceutical Market by Product Category
Company Profiles of Global Companies
Profiles of Key Domestic (Indian) Companies

The report includes incidence of conditions prevalent in the region discussed, health statistics related to the industry, birth rates, world population, regional population and issues affecting the market as a whole. Provided is an overview of demographics, information about products segments and market indicators, market estimates and forecasts.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study,

Kalorama Information conducted interviews with industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives. All market data pertains to the world market at the manufacturers’ level. The base year for data was 2007. Historical data was provided for the years 2005 and 2006, with forecast data provided for 2008 through 2012. Compound annual growth rates (CAGRs) are provided for the 2005-2007 and 2008-2012 periods for each region and/or segment covered. The forecasted market analysis for 2008-2012 was largely based on demographic trends, new developments, and global expansion.

CHAPTER ONE: EXECUTIVE SUMMARY

Overview
Scope and Methodology
Size and Growth of the Market
Key Issues and Trends Affecting the Market
Leading Competitors

CHAPTER TWO: INTRODUCTION

Overview
Intellectual Property Rights and Compulsory Licensing
Biosimilar Production
Ethical Issues Regarding DTC Advertising in Developing Regions
World Health
- Tobacco Use
- Obesity
World Economic Trends
- Purchasing Power Trends

CHAPTER THREE: MARKET ANALYSIS

Overview and Summary
Regulatory Environment
Economic Development
Healthcare Trends in India,ul>
Healthcare Professionals
- Demographics
  - Birth Rates
  - Life Expectancy
  - Mortality
  - Leading Causes of Death
- Key Product Segments and Market Indicators
  - Cardiovascular Drugs
  - Gastrointestinal Drugs
  - Infection Control Drugs
  - Neurotherapuetics and Central Nervous System Drugs
  - Oncology Drugs
  - Respiratory Drugs
  - Other Drugs
- Market Analysis
  - Product Segment Market Analysis
  - Competitive Outlook and Distribution
CHAPTER FOUR: GLOBAL LEADERS
- Overview
- Biocon Ltd.
- Cipla Ltd.
- Dr. Reddy’s Laboratories Ltd.
- GlaxoSmithKline
- Pfizer, Inc.
- Ranbaxy
- Sanofi-Aventis
- Wockhardt Ltd.

APPENDIX: LIST OF MAJOR COMPANIES TABLE OF EXHIBITS CHAPTER ONE: EXECUTIVE SUMMARY

Table 1-1: India Pharmaceutical Market Analysis, 2005-2007
Table 1-2: Forecasted India Pharmaceutical Market Analysis: 2008-2012
Figure 1-1: India Pharmaceutical Market Analysis: 2005-2012

CHAPTER TWO: INTRODUCTION

Table 2-1: Percent of Smokers by Country, Adult Population 15+
Table 2-2: Percent of Population that is Obese*, Estimated 2005
Table 2-3: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006
Figure 2-1: Total Healthcare Expenditures as a Percent of GDP by Country 2004 and 2006
Table 2-4: Gross National Income Comparison by Country 2000-2005
Figure 2-2: Gross National Income Growth by Country 2000-2005

CHAPTER THREE: MARKET ANALYSIS

Table 3-1: India Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
Figure 3-1: India Pharmaceutical Market as a Percentage of World Market, 2007 and 2012
Table 3-2: India’s Economic Profile
Table 3-3: Gross National Income Per Capita and Group Comparison for 2005 and 2006
Table 3-4: Healthcare Professionals in India by Type, Estimated 2004 and 2007
Figure 3-2: Healthcare Professionals in India by Type, Estimated 2004 and 2007
Table 3-5: India - Midyear Population, by Age and Sex, 2007 and 2012
Figure 3-3: India - Midyear Population, by Age, 2007 and 2012
Table 3-6: India Fertility Rates and Births, Estimated 2005, 2007; Projected 2008, 2025
Figure 3-4: India Fertility Rates and Births, Estimated 2005, 2007; Projected 2008, 2025
Table 3-7: India Life Expectancy at Birth, 1980, 1990, 2000, 2004, 2005, 2006, 2007; Projections, 2008 through 2012, and 2025
Figure 3-5: India Life Expectancy at Birth by Sex, 1980, 1990, 2000, Projections 2025
Table 3-8: India Mortality Rates and Numbers, 2005, 2007; Projected 2008, 2025
Figure 3-6: India Mortality Rates and Numbers, 2005, 2007; 2008, 2025
Table 3-9: India Leading Causes of Death, Estimated 2007
Figure 3-7: India Leading Causes of Death, Estimated 2007
Table 3-10: HIV Indicators, India
Figure 3-8: HIV Indicators, India:
Table 3-11: Tuberculosis Surveillance and Epidemiology, India
Figure 3-9: Tuberculosis Surveillance and Epidemiology, India
Table 3-12: India Malaria Data, 1990-2003
Figure 3-10: India Malaria Data, 1990-2003
Table 3-13: Cancer Surveillance and Epidemiology, India
Table 3-14: Estimated Cancer Incidence in India by Most Common Types of Cancer, Compared to World
Figure 3-12: Estimated Cancer Incidence in India by Most Common Types of Cancer, Compared to World, 2007
Table 3-15: India Pharmaceutical Market Analysis, 2005-2007
Table 3-16: Forecasted India Pharmaceutical Market Analysis: 2008-2012
Figure 3-13: India Pharmaceutical Market Analysis: 2005-2012
Table 3-17: India Pharmaceutical Market Analysis and Forecast by Product Segment, 2007 and 2012
Figure 3-14: India Pharmaceutical Market Analysis by Product Segment, 2007
Figure 3-15: India Pharmaceutical Market Forecast by Product Segment, 2012
Table 3-18: Estimated Sales of Pharmaceuticals in India by Local and Foreign Suppliers, 2007
Figure 3-16: Estimated Sales of Pharmaceuticals in India by Local and Foreign Suppliers, 2007

More India Infectious Diseases Reports

Anti-Infective Pharmaceuticals Market in India 2012 by Netscribes (India) Pvt. Ltd.
Anti-infective pharmaceuticals market in India is the largest contributor to domestic pharmaceutical sales, contributing around 18%. Since India has a huge patient pool, the Indian ...

Anti-Infective Pharmaceuticals Market in India 2011 by Netscribes (India) Pvt. Ltd.
Anti-infective pharmaceuticals market in India is the largest contributor to domestic pharmaceutical sales, contributing around 18%. Since India has a huge patient pool, the Indian ...

Asian Vaccine Markets: India, China, Japan, Korea, Indonesia and Rest of Asia by Kalorama Information
The Asian vaccine market is relatively small compared to its population, yet it is growing, and pharmaceutical manufacturers increasingly will look to boost sales from ...

The 2009-2014 Outlook for Streptococcal Infection Rapid Tests in India by Icon Group International, Inc.
This econometric study covers the latent demand outlook for streptococcal infection rapid tests across the states, union territories and cities of India. Latent demand (in ...

See all reports like this >>

More India Reports

D&B Country RiskLine Report: India by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: India by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report India January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Spirits - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Datamonitor's Spirits - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...

Wine - BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...

See all reports like this >>

Pharmaceutical Markets in India

Share this report

Other tasks

Research Assistance

Related Markets

Infectious Diseases Reports

Free Alert Me service